IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models.
- DOI
- 10.1158/1535-7163.mct-25-0484
- Published
- 2025 Dec 2
- Container
- Molecular cancer therapeutics
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-25-0484,
title = {IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models.},
author = {Huang H and Deckert J and Mysliwy J and Lodge A and Lutz RJ and Thurber GM},
year = {2025},
journal = {Molecular cancer therapeutics},
doi = {10.1158/1535-7163.mct-25-0484},
url = {https://doi.org/10.1158/1535-7163.mct-25-0484}
}RIS
TY - JOUR TI - IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models. AU - Huang H AU - Deckert J AU - Mysliwy J AU - Lodge A AU - Lutz RJ AU - Thurber GM PY - 2025 JO - Molecular cancer therapeutics DO - 10.1158/1535-7163.mct-25-0484 UR - https://doi.org/10.1158/1535-7163.mct-25-0484 ER -
APA
H, H., J, D., J, M., A, L., RJ, L., & GM, T. (2025). IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-25-0484
Source records
- pubmed · retrieved 2026-11-10T14:16:43.215Z
- europe-pmc · retrieved 2026-11-10T14:16:43.224Z